Multifunctional roles of lactoferrin: A critical overview

Cellular and Molecular Life Sciences

Volumn 62, Issue 22, 2005, Pages 2540-2548

  Ward, P P ^a   Paz, E ^a   Conneely, O M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anti cancer; Anti inflammatory; Antimicrobial; Bone morphogenesis; Cytokine; Iron; Lactoferrin

Indexed keywords

IRON; LACTOFERRIN; RECEPTOR; TRANSFERRIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIOSTASIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GRANULE; CELL GROWTH; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IMMUNITY; IRON BINDING CAPACITY; IRON METABOLISM; METASTASIS; NEUTROPHIL; NONHUMAN; PLEIOTROPY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; HUMANS; LACTOFERRIN; STRUCTURE-ACTIVITY RELATIONSHIP;

MAMMALIA;

EID: 28344447990     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5369-8     Document Type: Review

References (146)

1. Metz-Boutigue M. H., Jolles J., Mazurier J., Schoentgen F., Legrand D., Spik G. et al. (1984) Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145: 659-676
2. Anderson B. F., Baker H. M., Dodson E. J., Norris G. E., Rumball S. V., Waters J. M. et al. (1987) Structure of human lactoferrin at 3.2-A resolution. Proc. Natl. Acad. Sci. USA 84: 1769-1773
3. Anderson B. F., Baker H. M., Norris G. E., Rice D. W. and Baker E. N. (1989) Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol. 209: 711-734
4. Baker H. M., Anderson B. F. and Baker E. N. (2003) Dealing with iron: common structural principles in proteins that transport iron and heme. Proc. Natl. Acad. Sci. USA 100: 3579-3583
5. Ward P. P., Mendoza-Meneses M., Mulac-Jericevic B., Cunningham G. A., Saucedo-Cardenas O., Teng C. T. et al. (1999) Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140: 1852-1860
6. Masson P. L., Heremans J. F. and Dive C. (1966) An iron-binding protein common to many external secretions. Clinica Chimica Acta 14: 735-739
7. Levay P. F. and Viljoen M. (1995) Lactoferrin: a general review. Haematologica 80: 252-267
8. Teng C. T. (2002) Lactoferrin gene expression and regulation: an overview. Biochem. Cell Biol. 80: 7-16
9. Baggiolini M., De Duve C., Masson P. L. and Heremans J. F. (1970) Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J. Exp. Med. 131: 559-570
10. Rado T. A., Bollekens J., St Laurent G., Parker L. and Benz, E. J. Jr (1984) Lactoferrin biosynthesis during granulocytopoiesis. Blood 64: 1103-1109
11. Masson P. L., Heremans J. F. and Schonne E. (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658
12. Berliner N., Hsing A., Graubert T., Sigurdsson F., Zain M., Bruno E. et al. (1995) Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 85: 799-803
13. Ward P. P., Uribe-Luna S. and Conneely O. M. (2002) Lactoferrin and host defense. Biochem. Cell Biol. 80: 95-102
14. Brock J. H. (2002) The physiology of lactoferrin. Biochem Cell Biol. 80: 1-6
15. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C. et al. (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312 (Pt 3): 839-845
16. Appelmelk B. J., An Y. Q., Geerts M., Thijs B. G., de Boer H. A., MacLaren D. M. et al. (1994) Lactoferrin is a lipid A-binding protein. Infect. Immun. 62: 2628-2632
17. Mann D. M., Romm E. and Migliorini M. (1994) Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269: 23661-23667
18. Suzuki Y. A. and Lonnerdal B. (2002) Characterization of mammalian receptors for lactoferrin. Biochem. Cell Biol. 80: 75-80
19. Baveye S., Elass E., Mazurier J., Spik G. and Legrand D. (1999) Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med. 37: 281-286
20. Huettinger M., Retzek H., Hermann M. and Goldenberg H. (1992) Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. J. Biol. Chem. 267: 18551-18557
21. Suzuki Y. A., Shin K. and Lonnerdal B. (2001) Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 40: 15771-15779
22. Legrand D., Vigie K., Said E. A., Elass E., Massen M., Slomianny M. C. et al. (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271: 303-317
23. Damiens E., El Yazidi I., Mazurier J., Duthille I., Spik G. and Boilly-Marer Y. (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J. Cell. Biochem. 74: 486-498
24. Dhennin-Duthille I., Masson M., Damiens E., Fillebeen C., Spik G. and Mazurier J. (2000) Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell. Biochem. 79: 583-593
25. Oh S. M., Hahm D. H., Kim I. H. and Choi S. Y. (2001) Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J. Biol. Chem. 276: 42575-42579
26. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K. et al. (2004) The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18: 2268-2278
27. Haversen L., Ohlsson B. G., Hahn-Zoric M., Hanson L. A. and Mattsby-Baltzer I. (2002) Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immunol. 220: 83-95
28. Oh S. M., Pyo C. W., Kim Y. and Choi S. Y. (2004) Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 23: 8282-8291
29. Son K. N., Park J., Chung C. K., Chung D. K., Yu D. Y., Lee K. K. et al. (2002) Human lactoferrin activates transcription of IL-1beta gene in mammalian cells. Biochem. Biophys. Res. Commun. 290: 236-241
30. Garre C., Bianchi-Scarra G., Sirito M., Musso M. and Ravazzolo R. (1992) Lactoferrin binding sites and nuclear localization in K562(S) cells. J. Cell. Physiol. 153: 477-482
31. He J. and Furmanski P. (1995) Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721-724
32. Wessling-Resnick M. (2000) Iron transport. Annu. Rev. Nutr. 20: 129-151
33. Frazer D. M. and Anderson G. J. (2003) The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol. Dis. 30: 288-297
34. Andrews N. C. (2000) Iron homeostasis: insights from genetics and animal models. Nat. Rev. Genet. 1: 208-217
35. Brock J. H. (1980) Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch. Dis. Child. 55: 417-421
36. Iyer S. and Lonnerdal B. (1993) Lactoferrin, lactoferrin receptors and iron metabolism. Eur. J. Clin. Nutr. 47: 232-241
37. Sanchez L., Calvo M. and Brock J. H. (1992) Biological role of lactoferrin. Arch. Dis. Child. 67: 657-661
38. Davidson L. A. and Lonnerdal B. (1987) Persistence of human milk proteins in the breast-fed infant. Acta Paediatr. Scand. 76: 733-740
39. Fleming M. D., Trenor C. C. 3rd, Su M.A., Foernzler D., Beier D. R., Dietrich W. F. et al. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16: 383-386
40. Gunshin H., Mackenzie B., Berger U. V., Gunshin Y., Romero M. F., Boron W. F. et al. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488
41. Davidsson L., Kastenmayer P., Yuen M., Lonnerdal B. and Hurrell R. F. (1994) Influence of lactoferrin on iron absorption from human milk in infants. Pediatr. Res. 35: 117-124
42. Ward P. P., Mendoza-Meneses M., Cunningham G. A. and Conneely O. M. (2003) Iron status in mice carrying a targeted disruption of lactoferrin. Mol. Cell. Biol. 23: 178-185
43. Bullen J. J. (1972) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Proc. R. Soc. Med. 65: 1086
44. Baldwin D. A., Jenny E. R. and Aisen P. (1984) The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J. Biol. Chem. 259: 13391-13394
45. Caccavo D., Pellegrino N. M., Altamura M., Rigon A., Amati L., Amoroso A. et al. (2002) Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. J. Endotoxin. Res. 8: 403-417
46. Orsi N. (2004) The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17: 189-196
47. van Hooijdonk A. C., Kussendrager K. D. and Steijns J. M. (2000) In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br. J. Nutr. 84 Suppl. 1: S127-134
48. Bullen J. J., Rogers J. M. and Griffiths E. (1978) Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80: 1-35
49. Rainard P. (1986) Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet. Microbiol. 11: 387-392
50. Arnold R. R., Cole M. F. and McGhee J. R. (1977) A bactericidal effect for human lactoferrin. Science 197: 263-265
51. Ellison R. T. 3rd, Giehl T. J. and LaForce F. M. (1988) Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56: 2774-2781
52. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K. and Tomita M. (1992) Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121: 130-136
53. Wakabayashi H., Takase M. and Tomita M. (2003) Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 9: 1277-1287
54. Singh P. K., Parsek M. R., Greenberg E. P. and Welsh M. J. (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555
55. Britigan B. E., Hayek M. B., Doebbeling B. N. and Fick R. B. Jr (1993) Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61: 5049-5055
56. Rogan M. P., Taggart R. B., Greene C. M., Murphy P. G., O'Neill S. J. and McElvaney N. G. (2004) Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J. Infect. Dis. 190: 1245-1253
57. Conte M. P., Longhi C., Petrone G., Buonfiglio V., Di Santo S., Seganti L. et al. (1999) The anti-invasive effect of bovine lactoferrin requires an interaction with surface proteins of Listeria monocytogenes. Int. J. Immunopathol. Pharmacol. 12: 149-155
58. Longhi C., Conte M. P., Seganti L., Polidoro M., Alfsen A. and Valenti P. (1993) Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells. Med. Microbiol. Immunol. 182: 25-35
59. Wada T., Aiba Y., Shimizu K., Takagi A., Miwa T. and Koga Y. (1999) The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand J. Gastroenterol. 34: 238-243
60. Seganti L., Di Biase A. M., Marchetti M., Pietrantoni A., Tinari A. and Superti F. (2004) Antiviral activity of lactoferrin towards naked viruses. Biometals 17: 295-299
61. van der Strate B. W., Beljaars L., Molema G., Harmsen M. C. and Meijer D. K. (2001) Antiviral activities of lactoferrin. Antiviral Res. 52: 225-239
62. Groot F., Geijtenbeek T. B., Sanders R. W., Baldwin C. E., Sanchez-Hernandez M., Floris R. et al. (2005) Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN - gp120 interaction. J. Virol. 79: 3009-3015
63. Plaut A. G., Qiu J. and St Geme J. W. 3rd (2000) Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 19 Suppl. 1: S148-152
64. Gomez H. F., Ochoa T. J., Carlin L. G. and Cleary T. G. (2003) Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Dis. 187: 87-95
65. Ochoa T.J., Noguera-Obenza M., Ebel F., Guzman C.A., Gomez H.F. and Cleary T.G. (2003) Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 71: 5149-5155
66. Qiu J., Hendrixson D. R., Baker E. N., Murphy T. E. St Geme J. W. 3rd and Plaut A. G. (1998) Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc. Natl. Acad. Sci. USA 95: 12641-12646
67. Hendrixson D. R., Qiu J., Shewry S. C., Fink D. L., Petty S., Baker E. N. et al. (2003) Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol. Microbiol. 47: 607-617
68. Guillen C., McInnes I. B., Vaughan D. M., Kommajosyula S., Van Berkel P. H., Leung B. P. et al. (2002) Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168: 3950-3957
69. Shimizu K., Matsuzawa H., Okada K., Tazume S., Dosako S., Kawasaki Y. et al. (1996) Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol. 141: 1875-1889
70. Shaper M., Hollingshead S. K., Benjamin W. H. Jr and Briles D. E. (2004) PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]. Infect. Immun. 72: 5031-5040
71. Schryvers A. B., Bonnah R., Yu R. H., Wong H. and Retzer M. (1998) Bacterial lactoferrin receptors. Adv. Exp. Med. Biol. 443: 123-133
72. Dial E. J. and Lichtenberger L. M. (2002) Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem. Cell Biol. 80: 113-117
73. Kruzel M. L., Harari Y. Chen C. Y. and Castro G. A. (2000) Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation 24: 33-14
74. Lee W. J., Farmer J. L., Hilty M. and Kim Y. B. (1998) The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66: 1421-1426
75. Ward P. P., Piddington C. S., Cunningham G. A., Zhou X., Wyatt R. D. and Conneely O. M. (1995) A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology 13: 498-503
76. Zagulski T., Lipinski P., Zagulska A., Broniek S. and Jarzabek Z. (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70: 697-704
77. Slater K. and Fletcher J. (1987) Lactoferrin derived from neutrophils inhibits the mixed lymphocyte reaction. Blood 69: 1328-1333
78. Machnicki M., Zimecki M. and Zagulski T. (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74: 433-439
79. Crouch S. P., Slater K. J. and Fletcher J. (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240
80. Kaisho T. and Akira S. (2004) Pleiotropic function of Toll-like receptors. Microbes Infect. 6: 1388-1394
81. Britigan B. E., Lewis T. S., Waldschmidt M., McCormick M. L. and Krieg A. M. (2001) Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167: 2921-2928
82. Kawamata T., Tooyama I., Yamada T., Walker D. G. and McGeer P. L. (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142: 1574-1585
83. Leveugle B., Spik G., Perl D. P., Bouras C., Fillit H. M. and Hof P. R. (1994) The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 650: 20-31
84. Fillebeen C., Ruchoux M. M., Mitchell V., Vincent S., Benaissa M. and Pierce A. (2001) Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res. Mol. Brain Res. 96: 103-113
85. Sugi K., Saitoh O., Hirata I. and Katsu K. (1996) Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am. J. Gastroenterol. 91: 927-934
86. Uchida K., Matsuse R., Tomita S., Sugi K., Saitoh O. and Ohshiba S. (1994) Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer. Clin. Biochem. 27: 259-264
87. Dwarakanath A. D., Finnie I. A., Beesley C. M., O'Dowd G. M., Nash J., Tsai H. H. et al. (1997) Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis. Clin. Sci. 92: 307-313
88. Zweiman B., Kucich U., Shalit M., Von Allmen C., Moskovitz A., Weinbaum G. et al. (1990) Release of lactoferrin and elastase in human allergic skin reactions. J. Immunol. 144: 3953-3960
89. van de Graaf E. A., Out T. A., Kobesen A. and Jansen H. M. (1991) Lactoferrin and secretory IgA in the bronchoalveolar lavage fluid from patients with a stable asthma. Lung 169: 275-283
90. Decoteau E., Yurchak A. M., Partridge R. E. and Tomasi T. B. Jr (1972) Lactoferrin in synovial fluid of patients with inflammatory arthritis. Arthritis Rheum. 15: 324-325
91. Bennett R. M., Eddie-Quartey A. C. and Holt P. J. (1973) Lactoferrin - an iron binding protein in synovial fluid. Arthritis Rheum. 16: 186-190
92. Kimber I., Cumberbatch M., Dearman R. J., Ward P., Headon D. R. and Conneely O. M. (1998) Regulation by lactoferrin of epidermal Langerhans cell migration. Adv. Exp. Med. Biol. 443: 251-255
93. Cumberbatch M., Dearman R. J., Uribe-Luna S., Headon D. R., Ward P. P., Conneely O. M. et al. (2000) Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 100: 21-28
94. Griffiths C. E., Cumberbatch M., Tucker S. C., Dearman R. J., Andrew S., Headon D. R. et al. (2001) Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol. 144: 715-725
95. Cumberbatch M., Bhushan M., Dearman R. J., Kimber I. and Griffiths C. E. (2003) IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin. Exp. Immunol. 132: 352-359
96. Togawa J., Nagase H., Tanaka K., Inamori M., Umezawa T., Nakajima A. et al. (2002) Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G187-195
97. Togawa J., Nagase H., Tanaka K., Inamori M., Nakajima A., Ueno N. et al. (2002) Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17: 1291-1298
98. Haversen L. A., Baltzer L., Dolphin G., Hanson L. A. and Mattsby-Baltzer I. (2003) Anti-inflammatory activities of human lactoferrin in acute dextran sulphate-induced colitis in mice. Scand. J. Immunol. 57: 2-10
99. Dial E. J., Dohrman A. J., Romero J. J. and Lichtenberger L. M. (2005) Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J. Pharm. Pharmacol. 57: 93-99
100. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K. and Harada E. (2004) Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci. 66: 149-154
101. Birgens H. S., Karle H., Hansen N. E. and Ostergaard Kristensen L. (1984) Lactoferrin receptors in normal and leukaemic human blood cells. Scand. J. Haematol. 33: 275-280
102. Birgens H. S., Hansen N. E., Karle H. and Kristensen L. O. (1983) Receptor binding of lactoferrin by human monocytes. Br. J. Haematol. 54: 383-391
103. Van Snick J. L. and Masson P. L. (1976) The binding of human lactoferrin to mouse peritoneal cells. J. Exp. Med. 144: 1568-1580
104. Mazurier J., Legrand D., Hu W. L., Montreuil J. and Spik G. (1989) Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur. J. Biochem. 179: 481-187
105. Ghio A. J., Carter J. D., Dailey L. A., Devlin R. B. and Samet J. M. (1999) Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure. Am. J. Physiol. 276: L933-940
106. Guillen C., McInnes I. B., Vaughan D., Speekenbrink A. B. and Brock J. H. (2000) The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum. 43: 2073-2080
107. Elrod K. C., Moore W. R., Abraham W. M. and Tanaka R. D. (1997) Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am. J. Respir. Crit. Care Med. 156: 375-381
108. Bezault J., Bhimani R., Wiprovnick J. and Furmanski P. (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54: 2310-2312
109. Wolf J. S., Li D., Taylor R. J. and O'Malley B. W. Jr (2003) Lactoferrin inhibits growth of malignant tumors of the head and neck. ORL J. Otorhinolaryngol Relat. Spec. 65: 245-249
110. Wang W. P., Iigo M., Sato J., Sekine K., Adachi I. and Tsuda H. (2000) Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 91: 1022-1027
111. Shimamura M., Yamamoto Y., Ashino H., Oikawa T., Hazato T., Tsuda H. et al. (2004) Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer. 111: 111-116
112. Yoo Y. C., Watanabe S., Watanabe R., Hata K., Shimazaki K. and Azuma I. (1997) Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res. 88: 184-190
113. Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M. A. and Tsuda H. (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 17: 35-40
114. Tsuda H., Sekine K., Fujita K. and Ligo M. (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem. Cell Biol. 80: 131-136
115. Ushida Y., Sekine K., Kuhara T., Takasuka N., Iigo M., Maeda M. et al. (1999) Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn. J. Cancer Res. 90: 262-267
116. Tanaka T., Kawabata K., Kohno H., Honjo S., Murakami M., Ota T. et al. (2000) Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn. J. Cancer Res. 91: 25-33
117. Fujita K., Ohnishi T., Sekine K., Iigo M. and Tsuda H. (2002) Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx)-inducedCYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Jpn. J. Cancer Res. 93: 616-625
118. Masuda C., Wanibuchi H., Sekine K., Yano Y. Otani S., Kishimoto T. et al. (2000) Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4- hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn. J. Cancer Res. 91: 582-588
119. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D. J., Asamoto M. et al. (1997) Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88: 523-526
120. Varadhachary A., Wolf J. S., Petrak K., O'Malley B. W. Jr, Spadaro M., Curcio C. et al. (2004) Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int. J. Cancer 111: 398-403
121. Kuhara T. Iigo M., Itoh T., Ushida Y., Sekine K., Terada N. et al. (2000) Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr. Cancer 38: 192-199
122. Campbell T., Skilton R. A., Coombes R. C., Shousha S., Graham M. D. and Luqmani Y. A. (1992) Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br. J. Cancer 65: 19-26
123. Panella T. J., Liu Y. H., Huang A. T. and Teng C. T. (1991) Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells and breast cancer. Cancer Res. 51: 3037-3043
124. Penco S., Caligo M. A., Cipollini G., Bevilacqua G. and Garre C. (1999) Lactoferrin expression in human breast cancer. Cancer Biochem. Biophys. 17: 163-178
125. Teng C., Gladwell W., Raphiou I. and Liu E. (2004) Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 17: 317-323
126. Benaissa M., Peyrat J. P., Hornez L., Mariller C., Mazurier J. and Pierce A. (2005) Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int. J. Cancer 114: 299-306
127. Siebert P. D. and Huang B. C. (1997) Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc. Natl. Acad. Sci. USA 94: 2198-2203
128. Xiao Y., Monitto C. L., Minhas K. M. and Sidransky D. (2004) Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin. Cancer Res. 10: 8683-8686
129. Fujita K., Matsuda E., Sekine K., Iigo M. and Tsuda H. (2004) Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett. 213: 21-29
130. Fujita K., Matsuda E., Sekine K., Iigo M. and Tsuda H. (2004) Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25: 1961-1966
131. Legrand D., Elass E., Pierce A. and Mazurier J. (2004) Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 17: 225-229
132. Horwitz D. A., Bakke A. C., Abo W. and Nishiya K. (1984) Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J. Immunol. 132: 2370-2374
133. Shau H., Kim A. and Golub S. H. (1992) Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol. 51: 343-349
134. Damiens E., Mazurier J., el Yazidi I., Masson M., Duthille I., Spik G. et al. (1998) Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta 1402: 277-287
135. Reddy P. (2004) Interleukin-18: recent advances. Curr. Opin. Hematol. 11: 405-110
136. Iigo M., Shimamura M., Matsuda E., Fujita K., Nomoto H., Satoh J. et al. (2004) Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 25: 36-44
137. Tomita M., Wakabayashi H., Yamauchi K., Teraguchi S. and Hayasawa H. (2002) Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell. Biol. 80: 109-112
138. Cao R., Farnebo J., Kurimoto M. and Cao Y. (1999) Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 13: 2195-2202
139. Lorget F., Clough J., Oliveira M., Daury M.C., Sabokbar A. and Offord E. (2002) Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem. Biophys. Res. Commun. 296: 261-266
140. Cornish J., Callon K. E., Naot D., Palmano K. P., Banovic T., Bava U. et al. (2004) Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145: 4366-4374
141. Hagiwara T., Shinoda I., Fukuwatari Y. and Shimamura S. (1995) Effects of lactoferrin and its peptides on proliferation of rat intestinal epithelial cell line, IEC-18, in the presence of epidermal growth factor. Biosci. Biotechnol. Biochem. 59: 1875-1881
142. Nichols B. L., McKee K. S., Henry J. F. and Putman M. (1987) Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells. Pediatr. Res. 21: 563-567
143. Nichols B. L., McKee K. S. and Huebers H. A. (1990) Iron is not required in the lactoferrin stimulation of thymidine incorporation into the DNA of rat crypt enterocytes. Pediatr. Res. 27: 525-528
144. Oguchi S., Walker W. A. and Sanderson I. R. (1995) Iron saturation alters the effect of lactoferrin on the proliferation and differentiation of human enterocytes (Caco-2 cells). Biol. Neonate 67: 330-339
145. Hashizume S., Kuroda K. and Murakami H. (1983) Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium. Biochim. Biophys. Acta 763: 377-382
146. Oria R., Alvarez-Hernandez X., Liceaga J. and Brock J. H. (1988) Uptake and handling of iron from transferrin, lactoferrin and immune complexes by a macrophage cell line. Biochem. J. 252: 221-225